After Hours Summary: COST +2% following earnings, MENT +6% on Elliot active stake news, WMT +0.5% with Costco/analyst initiation... CAMP -13% on earnings/guidance, THLD -70% discontinuing Tarloxotinib Program/cutting staff newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: AEHR +7.4% (light volume), COST +1.7% (also responds to the partial jury verdict returned in the case brought by Tiffany)
Companies trading higher in after hours in reaction to news: AUPH +13.3% (announces that voclosporin achieves primary and all pre-specified secondary endpoints in Phase IIb AURA-LV study for Lupus Nephritis), MENT +5.6% (Elliot Mgmt discloses 8.1% active stake -- has communicated with management and Board about a broad range of operational and strategic matters), OZM +5.1% (confirms reaching settlements w/ the DOJ and the SEC; will pay a total penalty of $412 mln; entered into a securities purchase agreement with certain executive managing directors), CEMP +4.4% (light volume - announces interim results showing anti-NASH effects in the first six nonalcoholic steatohepatitis patients dosed with solithromycin in a Phase 2 study), NVFY +1.2% (to sell NOVA BVI and its subsidiaries for $8.5 mln to Kuka Design), HLIT +1.2% (Comcast confirms 6.6% passive stake -- the cos entered into a warrant agreement this week), ZNGA +1.1% (appoints Gerard Griffin as CFO effective immediately), WMT +0.5% (initiated with an Overweight at KeyBanc Capital Markets; tgt $90), AA +0.5% (approves proposed separation; separation is scheduled to become effective before the opening of the market on November 1, 2016), PSX +0.3% (upgraded to Neutral from Sell at Goldman)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CAMP -12.9%,
Companies trading lower in after hours in reaction to news: THLD -67% (to discontinue investment in its Tarloxotinib Program after interim data; implementing workforce reduction), MIRN -17.1% (Mirna Therapeutics Investigational New Drug for MRX34 has been placed on full clinical hold), ABUS -13.9% (reports interim results from the first two cohorts of the ongoing ARB-1467 Phase II multi-dose clinical trial in chronically infected HBV patients), VNRX -8.5% (announces proposed public offering of common stock), DCTH -5.8% (intends to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering), STAY -4.6% (commences 13 mln paired shares offering by certain selling stockholders affiliated with Centerbridge Partners, Paulson & Co and The Blackstone Group), IRT -0.9% (prices public offering of 25 mln shares of common stock at $9.00 per share for total gross proceeds of $225.0 mln)
Closing Market Summary: Deutsche Bank Fears Startle MarketThe stock market ended the Thursday affair on a lower note as concerns regarding Deutsche Bank's (DB 11.48, -0.82) capital position weighed on the major averages. The Dow Jones Industrial Average (-1.1%) finished slightly behind the Nasdaq Composite (-0.9%) and the S&P 500 (-0.9%).
Equity indices began the day on a quiet note, looking to consolidate after yesterday's oil-fueled risk rally. The benchmark index occupied a narrow nine-point trading range through the first half of trade as participants mulled over a recently-minted production cap agreement. OPEC surprised participants yesterday by announcing that it would limit production to between 32.5 million and 33.0 million barrels per day. However, specific terms of the agreement will not be released or put into effect until the oil collective meets on November 30.
The broader market broke lower near midday as reports indicated that approximately ten hedge funds have reduced their exposure to Deutsche Bank in recent days. The stock was down as much as 9.1%, ending lower by 6.7%. The German lender issued a statement in the afternoon, asserting that there had been recent outflows from its hedge fund business, but that Deutsche Bank's prime brokerage division remains profitable. Recall that capital concerns increased after the U.S. Department of Justice requested that the bank pay $14 billion to settle civil claims associated with the residential mortgage-backed securities crisis. The major averages notched session lows shortly after midday as heavily-weighted financials (-1.5%) and health care (-1.8%) led to the downside. The S&P 500 settled lower by 0.9%, testing technical support near the 2153/2151 price level. All eleven sectors finished in the red with utilities (-1.5%), financials (-1.5%), and health care (-1.8%) underperforming while energy (-0.1%) led to the upside.
The economically-sensitive financial sector (-1.5%) moved lower in sympathy with Deutsche Bank (DB 11.48, -0.82) as participants expressed concerns over the global banking landscape. Meanwhile, Wells Fargo (WFC 44.37, -0.94) declined 2.1% after CEO John Stumpf testified before the House Financial Services Committee. The congressional hearing was again heated as lawmakers questioned the sales tactics that led to the creation of more than two million fake deposit and credit-card accounts. The broader space extended its monthly loss to 4.2%, trailing the remaining sectors.
In the health care sector (-1.8%), biotechnology underperformed, evidenced by the 3.1% decline in the iShares Nasdaq Biotechnology ETF (IBB 285.87, -9.21). Mylan (MYL 38.47, -1.75) fell 4.4% after the CMS indicated that it had previously informed the company that it had misclassified its EpiPen device under the Medicaid Drug Rebate program. Recall that a group of U.S. lawmakers have recently pushed for the DoJ to investigate Mylan for this misclassification.
In the technology sector (-0.6%), the high-beta chipmakers outperformed, evidenced by the 1.3% gain in the PHLX Semiconductor Index. NXP Semiconductor (NXPI 96.12, +13.88) rallied 16.9% after reports indicated that Qualcomm (QCOM 67.45, +4.00) could be looking to acquire the company. Conversely, Apple (AAPL 112.17, -1.78) underperformed after it was removed from Barclay's Top Pick list. The firm also lowered its 2016 smartphone revenue and unit growth estimates for Apple.
The commodity-sensitive energy sector (-0.1%) finished at the top of the board as crude oil extended its rally. WTI crude finished higher by 1.4% ($47.73/bbl; +$0.66), showing marked resilience to the downturn in the broader market.
Treasuries ended on a higher note with yields slipping through the curve. The yield on the 10-yr note finished lower by one basis point at 1.56%.
Today's participation was above the recent average as more than 971 million shares changed hands on the NYSE floor.
Today's economic data included the third estimate of second quarter GDP, weekly initial claims, International Trade in Goods for August, and Pending Home Sales for August:
- The third estimate for second quarter GDP checked in at 1.4% (consensus 1.3%), up from the second estimate of 1.1%. The GDP Deflator was unchanged at 2.3%.
- Initial claims for the week ending September 24 increased by 3,000 to 254,000 (consensus 259,000), marking the 82nd straight week they have been below 300,000.
- Continuing claims for the week ending September 17 decreased by 46,000 to 2.062 million.
- The Advance International Trade in Goods report for August showed a narrowing in the goods deficit to $58.4 billion from an upwardly revised $58.8 billion (from -$59.3 billion) in July.
- Pending Home Sales for August fell by 2.4% while the consensus expected an increase of 1.0%. Separately, the July reading was revised to 1.2% from 1.3%.
Tomorrow's economic data will include Personal Income (consensus +0.2%), Personal Spending consensus +0.2%), and Core PCE Prices (consensus +0.2%) for August, which will each be released at 8:30 ET. Separately, Chicago PMI (consensus 52.0) and the final reading of the University of Michigan Sentiment Index for September (consensus 90.0) will cross the wires at 9:45 ET and 10:00 ET, respectively.
- Russell 2000: +9.2% YTD
- S&P 500: +5.2% YTD
- Nasdaq: +5.2% YTD
- Dow Jones: +4.1% YTD